ACS Chemical Biology · 2018 · 60 citations · 29 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryMolecular OncologyCancer GlycobiologyExtracellular Matrix GlycansGlycan-protein InteractionsTargeted Cancer TherapyAnticancer ActivityDruggable Target DiscoveryEndoglycosidase ActivityExtracellular Polysaccharide MatrixGlycan-based Cancer TherapeuticsHeparan Sulfate In CancerSulfated PolysaccharidesTherapeutic Glycan Design
potency for heparanase inhibition equivalent to comparator compounds in clinical development, and potently inhibit metastasis and growth of human myeloma tumor cells in a mouse xenograft model. Importantly, they lack anticoagulant activity and cytotoxicity, and also inhibit angiogenesis. They provide a new candidate class for anticancer and wider therapeutic applications, which could benefit from targeted heparanase inhibition.
29
David M. Ornitz, Avner Yayon, John G. Flanagan et al. · Molecular and Cellular Biology · 1992 · 625 citations · Full text
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Natali Gil, Rachel Goldberg, Tzahi Neuman et al. · Diabetes · 2011 · 193 citations · Full text